Southwest Oncology Group study S0413: A phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer

S. Iqbal, B. Goldman, C. M. Fenoglio-Preiser, H. J. Lenz, W. Zhang, K. D. Danenberg, S. I. Shibata, C. D. Blanke

Research output: Contribution to journalArticlepeer-review

115 Scopus citations

Fingerprint

Dive into the research topics of 'Southwest Oncology Group study S0413: A phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences